MiNK Therapeutics Insider Trades

INKT

Track insider trading activity from MiNK Therapeutics executives and directors. See which insiders are buying and selling INKT stock.

Trades Last 12 Months

INKT Price

All Insider Trades for MiNK Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Corvese Brian Director
Holding Value $678k 53,137 shares
Last Trade
Jun 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.9k 1,444 shares
$12.38
$12.76
Holding Value $44.1k 3,458 shares
Last Trade
Jun 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$13.5k 1,091 shares
$12.38
$12.76
Wiinberg Ulf Director
Holding Value $289k 22,650 shares
Last Trade
Jun 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14k 1,131 shares
$12.38
$12.76
Behner Peter Director
Holding Value $292k 22,919 shares
Last Trade
Jun 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$16.3k 1,313 shares
$12.38
$12.76
Ryan Barbara Director
Holding Value $299k 23,469 shares
Last Trade
Jun 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.8k 1,434 shares
$12.38
$12.76
Buell Jennifer Chief Executive Officer
Holding Value $739k 57,942 shares
Last Trade
Jan 02, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$111k 10,024 shares
$11.12
$12.76
Wiinberg Ulf Director
Holding Value $68.8k 5,395 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$60k 5,395 shares
$11.12
$12.76
Holding Value $244k 19,126 shares
Last Trade
Dec 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$13.5k 1,218 shares
$11.09
$12.76
Van Dijk Marcus Antonius Chief Scientific Officer
Holding Value $2.18M 171,078 shares
Last Trade
Jan 16, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.62M 186,078 shares
$8.70
$12.76
Agenus Inc 10% owner
Holding Value $278M 21,772,863 shares
Last Trade
Oct 16, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.72k 429 shares
$11.00
$12.76
Baldoni John Director
Holding Value $526k 41,193 shares
Last Trade
Sep 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$144k 9,846 shares
$14.60
$12.76
Armen Garo H Director
Holding Value $23.8M 1,866,400 shares
Last Trade
May 05, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.58M 100,000 shares
$15.80
$12.76
Holding Value $0 0 shares
Last Trade
Oct 13, 2021 Sale
No data
No data
$12.76

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up